DUBLIN--(
BUSINESS WIRE
)--The
"Opportunities in Personalized Nutrition Solutions, Microbiome Testing for Optimal Health, Gene Circuits and Advanced Therapeutics"
report has been added to
ResearchAndMarkets.com's
offering.
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) focuses on host microbiome analysis driven personalized nutrition solutions and precision probiotics development. Newer drug delivery carriers such as RBC derived vesicles, non viral gene delivery carriers and a few innovations around gene circuits for advanced therapeutics have also been covered.
The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.
The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.
Key Topics Covered:
Innovations in Life Science, Health & Wellness
Red Blood Cell Extracellular Vesicles for Non-viral Gene Therapy
Value Proposition of Carmine Therapeutics
Carmine Therapeutics - Investor Dashboard
Genetic Lysis Circuit Based Therapeutics That Targets Hypoxic Cancerous Tumor Areas
Gencirq - Value Proposition
Gencirq - Investor Dashboard
Mushroom-derived Personal Care Products To Improve Hair Strand Properties
Active Concepts - Value Proposition
Active Concepts - Investor Dashboard
Naturally Derived Optimized Peptides For Wide-ranging Health Benefits
Nuritas - Value Proposition
Nuritas - Investor Dashboard
Cloud Based Bioreactor Design for Process Monitoring and Optimization
Culture Bioscience's Value Proposition
Culture Bioscience - Investor Dashboard
Developing Cell-free Manufacturing Platform for Gene Therapy
Intergalactic Therapeutics's Value Proposition
Intergalactic Therapeutics - Investor Dashboard
Customized Mixed Consortia Probiotics Tailored to the Patient's Gut
Probiotics with the Potential to Address Autism Spectrum Disorder
Sun Genomics - Investor Dashboard
AI-based Precision Nutrition Guidance Solution for Optimal Nutrition
Personalized Solution Enabling Optimal Health and Performance
Me Biosciences Inc. - Investor Dashboard
Oral Insulin Tablets as a Promising Alternative to Insulin Injections
The University of British Columbia's Value Proposition
Next Generation Monoclonal Antibody for Treating Refractive Rheumatoid Arthritis
The Medical University of Vienna's Value Proposition
Multi-layered Gene Circuits Open Up New Avenues in Next-generation Medicine Discovery
University of Washington's Value Proposition
Key Contacts
Appendix
Criteria for Rating of Innovations - Explanation
Legal Disclaimer
Companies Mentioned
Active Concepts
Carmine Therapeutics
Culture Bioscience
Gencirq
Intergalactic Therapeutics
Me Biosciences Inc
Nuritas
Sun Genomics
For more information about this report visit
https://www.researchandmarkets.com/r/fjvtt